The Shaw Group ( SHAW) target raised at Goldman Sachs. Shares of SHAW now seen reaching $27, Goldman Sachs said. Improved execution, awards and catalysts prop shares near-term. Neutral rating. Walgreen ( WAG) estimates lowered at Guggenheim through 2012. No last ditch settlement with ESRX. Maintain $39 price target and buy rating. Walgreen Company numbers lowered at Goldman Sachs. Shares of WAG now seen reaching $38, Goldman Sachs said. Estimates also lowered on poor quarter report. Buy rating. >To submit a news tip, email: firstname.lastname@example.org.